OPADE, NCT06550037: Optimize and Predict Antidepressant Efficacy for Patient With MDD Using Multi-omics Analysis and AI-predictive Tool |
|
|
| Recruiting | N/A | 350 | Europe | | Alessio Fasano, University of Siena, Fundació Eurecat, Perseus Biomics, ARTIFICIAL INTELLIGENCE EXPERT SRL, Mama Health Technologies GmbH, Protobios OU, Cephalgo, Biokeralty Research Institute, Sanitas University, Accare, Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta, Istanbul Medipol University Hospital, CEINGE, Fondazione di ricerca biomedica EBRIS | Major Depressive Disorder | 08/25 | 05/27 | | |
